-
What is PRP? Platelet-rich plasma (PRP) is a collection of a person’s own platelets and other regenerative cells that can enhance healing and tissue regeneration. It is created by taking a small sample of blood and spinning it in a centrifuge to separate the various cells and to concentrate the platelets. Why Tropocells® PRP? The Tropocells® PRP system consistently provides an optimal platelet rich plasma formula:
- No Red blood cells (RBCs are toxic to cartilage and can induce a painful inflammatory flare)
- Low neutrophils (neutrophils promote inflammation and tissue breakdown)
- High number of monocytes (the cells that encourage healing) This high-quality system has high platelet yields so less blood needs to be drawn for treatment
-
What is PRP? Platelet-rich plasma (PRP) is a collection of a person’s own platelets and other regenerative cells that can enhance healing and tissue regeneration. It is created by taking a small sample of blood and spinning it in a centrifuge to separate the various cells and to concentrate the platelets. Why Tropocells® PRP? The Tropocells® PRP system consistently provides an optimal platelet rich plasma formula:
- No Red blood cells (RBCs are toxic to cartilage and can induce a painful inflammatory flare)
- Low neutrophils (neutrophils promote inflammation and tissue breakdown)
- High number of monocytes (the cells that encourage healing) This high-quality system has high platelet yields so less blood needs to be drawn for treatment
-
Papilocare 77 Cannulas This 77 Cannula product variation is intended for a woman's full 6 month Papilocare application. Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.
-
Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.
-
Papilocare 55 Cannulas This 55 Cannula product variation is intended for a woman's month 2 to 6 Papilocare application. Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.
-
Papilocare 21 Cannulas This 21 Cannula product variation is intended for a woman's first month of Papilocare application. Who can use Papilocare? The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL). What is Papilocare and how does it work? Papilocare is the first clinically proven treatment solution for HPV-induced low grade (ASCUS, LSIL, CIN 1) lesions of the cervical transformation zone. The Coriolus versicolor-based vaginal gel is specifically formulated to activate the three modifiable HPV-induced low grade lesion repair factors. 1. Re-epithelialisation of the cervical transformation zone 2. Rebalancing the vaginal microbiota 3. Counteracting the non-inflammatory microenvironment that HPV creates.
-
The patented formulation of Lit-Control pH Up helps to keep the urinary system healthy, by inhibiting the formation of crystals and increasing the urine pH. The Lit-Control pH Meter medical device is specifically designed to quickly, easily and accurately measure the urine pH. Its innovative technology, endorsed by the medical community, has allowed it to become the fastest and most efficient solution on the market in urine pH measurement and control.
-
The patented formulation of Lit-Control pH Down helps to keep the urinary system healthy, by inhibiting the formation of crystals and decreasing the urine pH. The Lit-Control pH Meter medical device is specifically designed to quickly, easily and accurately measure the urine pH. Its innovative technology, endorsed by the medical community, has allowed it to become the fastest and most efficient solution on the market in urine pH measurement and control.